Microvascular changes at different stages of chronic kidney disease. Issue 2 (19th December 2020)

• Record Type: Journal Article
• Authors: Kannenkeril, Dennis; Frost, Shaun; Nolde, Janis M.; Kiuchi, Márcio Galindo; Carnagarin, Revathy; Lugo‐Gavidia, Leslie Marisol; Chan, Justine; Joyson, Anu; Matthews, Vance B.; Herat, Lakshini Y.; Azzam, Omar; Mehdizadeh, Maryam; Vignarajan, Janardhan; Kanagasingam, Yogesan; Schlaich, Markus P.
• Is Part Of: Journal of clinical hypertension. Volume 23:Issue 2(2021)
• Page Start: 309
• Page End: 316
• Publication Date: 2020-12-19
• Subjects: chronic kidney disease -- glomerular filtration rate -- microvascular change -- retinal vessel caliber hypertension sympathetic nervous system; Hypertension -- Periodicals; 616.132
• DOI: 10.1111/jch.14138
• Languages: English
• ISSNs: 1524-6175

Abstract

Abstract: Patients with progressing chronic kidney disease (CKD) are more likely to experience cardio‐ and cerebrovascular events than progressing to end‐stage renal disease. The authors explored whether retinal microvascular calibers differed with the degree of renal impairment and between the standard and extended optic disk and may serve as a simple additional tool for risk stratification in this highly vulnerable patient cohort. The authors analyzed central retinal arteriolar and venular equivalent calibers (CRAE, CRVE) at different retinal zones (zone B&C) using digital retinal imaging in hypertensive patients with stage 2 (n = 66) or stage 3 CKD (n = 30). Results were adjusted for age, sex, HbA1c, and 24‐hour diastolic blood pressure. Mean eGFR was 77.7 ± 8.9 and 48.8 ± 7.9 ml/min/1.73 m 2 for stage 2 and 3 CKD, respectively. CRAE and CRVE in zones B and C were significantly lower in patients with stage 3 CKD compared to patients with stage 2 CKD (CRAE‐B:141.1 ± 21.4 vs. 130.5 ± 18.9 µm, p = .030; CRAE‐C:137.4 ± 19.4 vs 129.2 ± 18.2 µm, p = .049; CRVE‐B:220.8 ± 33.0 vs. 206.0 ± 28.4 µm, p = .004; and CRVE‐C:215.9 ± 33.0 vs. 201.2 ± 25.1µm, p = .003). In patients with stage 2 CKD, CRAE‐B was higher than CRAE‐C (141.1 ± 21.4 vs. 137.4 ± 19.4µm, p < .001). In contrast, such a difference was not found in patients with stage 3 CKD. CRAE of both retinal zones correlated with eGFR for the entire cohort. In patients with stage 3 CKD, retinal narrowing is more pronounced compared to patients with stage 2 CKD. Whether the novel observation of difference in arteriolar caliber between zones B and C in stage 2 CKD could serve as an early marker of CKD progression warrants further investigation.